Biopharma layoffs aren't letting up
The Top Line
00:00
Intro
This chapter examines the significant trend of layoffs in the biopharma sector during the first half of 2025, with a particular focus on the peak in May. It discusses the potential causes behind these layoffs, the industry-wide implications, and the continued challenges in stabilizing the biotech market.
Transcript
Play full episode
